Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;88(3):1387-1391.
doi: 10.1111/bcp.14953. Epub 2021 Jun 26.

Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels

Affiliations

Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels

Pinar Bakir Ekinci et al. Br J Clin Pharmacol. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
The relationships of voriconazole and CRP levels in COVID‐19 and non COVID‐19 patients

References

    1. Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID‐19‐associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020;21(6):e149‐e162. 10.1016/S1473-3099(20)30847-1 - DOI - PMC - PubMed
    1. Elewa H, El‐Mekaty E, El‐Bardissy A, Ensom MH, Wilby KJ. Therapeutic drug monitoring of voriconazole in the management of invasive fungal infections: a critical review. Clin Pharmacokinet. 2015;54(12):1223‐1235. - PubMed
    1. Abdul‐Aziz MH, Alffenaar JC, Bassetti M, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med. 2020;46(6):1127‐1153. - PMC - PubMed
    1. Park WB, Kim NH, Kim KH, et al. The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. Clin Infect Dis. 2012;55(8):1080‐1087. - PubMed
    1. Van Wanrooy MJ, Span LF, Rodgers MG, et al. Inflammation is associated with voriconazole trough concentrations. Antimicrob Agents Chemother. 2014;58(12):7098‐7101. - PMC - PubMed